Search Results - Duchosal, M.A.

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

    Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry by Haouala, A., Zanolari, B., Rochat, B., Montemurro, M., Zaman, K., Duchosal, M.A., Ris, H.B., Leyvraz, S., Widmer, N., Decosterd, L.A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Hereditary Thrombophilia and Venous Thromboembolism: Critical Evaluation of the Clinical Implications of Screening

    Hereditary Thrombophilia and Venous Thromboembolism: Critical Evaluation of the Clinical Implications of Screening by Mazzolai, L, Duchosal, M.A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Determination of imatinib (Gleevec ®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection

    Determination of imatinib (Gleevec ®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection by Widmer, N, Béguin, A, Rochat, B, Buclin, T, Kovacsovics, T, Duchosal, M.A, Leyvraz, S, Rosselet, A, Biollaz, J, Decosterd, L.A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate

    A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate by Perrenoud, G., Messerli, F., Thierry, A.-C., Beltraminelli, N., Cousin, P., Fasel, N., Vallet, V., Demotz, S., Duchosal, M.A., Moulon, C.

    Published in Vaccine
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: